Projects

Protein energy wasting in children with chronic kidney disease: Exploring links to muscle health, physical activity and quality of life (WIN-CKD study)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - 2026

Project Lead

Dr Arpana I, Dr Sucharita S

Authors

Dr Arpana I, Dr Sucharita S

Project Status

ongoing

Project Type

CSIR